video thumbnail

Potential New Killer Cells for Cancer Immunotherapy

Duration: 30:23

Write A New Comment

1 Comments

...

olgak63@*.com

May 28 2022, 10:41 am

Video stopped at 15.55 min. ... ?  It started to play when I tried more than 30 min. later.

Potential New Killer Cells for Cancer Immunotherapy

This amazing find by the scientists from Memorial Sloan Kettering Cancer Center holds a lot of potential for immunotherapy of solid tumors. Let's review

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

URL list from Monday, Apr. 25 2022

FastStats - Older Persons Health
https://www.cdc.gov/nchs/fastats/older-american-health.htm

Trends in Causes of Death among Older Persons in the United States (October 2005)
https://www.cdc.gov/nchs/data/ahcd/agingtrends/06olderpersons.pdf

Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells: Cell
https://www.cell.com/cell/fulltext/S0092-8674(16)00003-9

Programme of self-reactive innate-like T cell-mediated cancer immunity | Nature
https://www.nature.com/articles/s41586-022-04632-1

Scientists identify potential new 'soldier' for cancer immunotherapy -- ScienceDaily
https://www.sciencedaily.com/releases/2022/04/220420133616.htm

About Us | Sloan Kettering Institute
https://www.mskcc.org/research/ski/about

New T cell immune response discovery points to ‘out-of-box’ cancer therapy options – Endpoints News
https://endpts.com/new-t-cell-immune-response-discovery-points-to-out-of-box-cancer-therapy-options/

Programme of self-reactive innate-like T cell-mediated cancer immunity
https://en.x-mol.com/paper/article/1516862209619566592

Immune Checkpoint Inhibitors - National Cancer Institute
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors

nci-vol-10396-150.jpg (1500×1200)
https://www.cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_enlarged/public/cgov_image/media_image/2019-09/nci-vol-10396-150.jpg?h=30063a04&itok=DGHB7TA1

Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors - PubMed
https://pubmed.ncbi.nlm.nih.gov/29990692/

Definition of CTLA-4 - NCI Dictionary of Cancer Terms - National Cancer Institute
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ctla-4

776560.jpg (3120×2400)
https://nci-media.cancer.gov/pdq/media/images/776560.jpg

USCS Data Visualizations - CDC
https://gis.cdc.gov/Cancer/USCS/#/Demographics/

FCER1G - Wikipedia
https://en.wikipedia.org/wiki/FCER1G

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Pharmacology

Related Videos